Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926478 · ClinicalTrials.gov registry record · Phase 1
Subconjunctival Humira for Boston Keratoprosthesis
A Phase 1 study, sponsored by Massachusetts Eye and Ear Infirmary.
- Not yet
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT06926478 is a Phase 1 study that has not yet begun recruiting, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 8 participants.
The verdict
NCT06926478, a Phase 1 study, has not yet begun recruiting, sponsored by Massachusetts Eye and Ear Infirmary.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial is studying the safety and tolerability of receiving an injection of adalimumab (Humira) during the Boston Keratoprosthesis (KPro) surgery.
Interventions
- DRUG Adalimumab Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06926478
The ClinicalTrials.gov registry entry for NCT06926478 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adalimumab Injection is the first listed.
NCT06926478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06926478 about?
NCT06926478 is a clinical study titled "Subconjunctival Humira for Boston Keratoprosthesis". This trial is studying the safety and tolerability of receiving an injection of adalimumab (Humira) during the Boston Keratoprosthesis (KPro) surgery.
What is the current status of trial NCT06926478?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2026-06-01. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT06926478?
The interventions under investigation include: Adalimumab Injection (DRUG).
Who is sponsoring clinical trial NCT06926478?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.